214 related articles for article (PubMed ID: 15690253)
21. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited.
Orchard TJ; Forrest KY; Ellis D; Becker DJ
Arch Intern Med; 1997 Sep; 157(16):1851-6. PubMed ID: 9290544
[TBL] [Abstract][Full Text] [Related]
22. Glycemic Control and Mortality in Diabetic Patients Undergoing Dialysis Focusing on the Effects of Age and Dialysis Type: A Prospective Cohort Study in Korea.
Park JI; Bae E; Kim YL; Kang SW; Yang CW; Kim NH; Lee JP; Kim DK; Joo KW; Kim YS; Lee H
PLoS One; 2015; 10(8):e0136085. PubMed ID: 26285034
[TBL] [Abstract][Full Text] [Related]
23. Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study.
Kim KJ; Choi J; Bae JH; Kim KJ; Yoo HJ; Seo JA; Kim NH; Choi KM; Baik SH; Kim SG; Kim NH
Diabetes Metab J; 2021 May; 45(3):368-378. PubMed ID: 33081424
[TBL] [Abstract][Full Text] [Related]
24. Use of Glycated Hemoglobin (A1c) as a Biomarker for Vascular Risk in Type 2 Diabetes: Its Relationship with Matrix Metalloproteinases-2, -9 and the Metabolism of Collagen IV and Elastin.
Kostov K; Blazhev A
Medicina (Kaunas); 2020 May; 56(5):. PubMed ID: 32403389
[No Abstract] [Full Text] [Related]
25. Microvascular Complications Associated With Rapid Improvements in Glycemic Control in Diabetes.
Gibbons CH; Goebel-Fabbri A
Curr Diab Rep; 2017 Jul; 17(7):48. PubMed ID: 28526993
[TBL] [Abstract][Full Text] [Related]
26. Correlation Between Extracutaneous Microvascular Complications and Diabetic Foot Ulcers in Patients with Type 2 Diabetes Mellitus.
Balaban J; Bijelic R; Milicevic S; Stanetic K; Grbic N
Med Arch; 2020 Dec; 74(6):444-449. PubMed ID: 33603269
[TBL] [Abstract][Full Text] [Related]
27. Glycated hemoglobin variability and microvascular complications in patients with type 1 diabetes mellitus.
Er E; Ata A; Evin F; Altınok YA; Demir G; Özen S; Darcan Ş; Gökşen D
J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1533-1537. PubMed ID: 33581707
[TBL] [Abstract][Full Text] [Related]
28. Treatment induced neuropathy of diabetes-Long term implications in type 1 diabetes.
Gibbons CH
J Diabetes Complications; 2017 Apr; 31(4):715-720. PubMed ID: 28159476
[TBL] [Abstract][Full Text] [Related]
29. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
Yang CY; Su PF; Hung JY; Ou HT; Kuo S
Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
[TBL] [Abstract][Full Text] [Related]
30. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
[TBL] [Abstract][Full Text] [Related]
31. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival.
Williams ME; Lacson E; Teng M; Ofsthun N; Lazarus JM
Kidney Int; 2006 Oct; 70(8):1503-9. PubMed ID: 16941022
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
[TBL] [Abstract][Full Text] [Related]
33. Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.
Bjerg L; Hulman A; Carstensen B; Charles M; Jørgensen ME; Witte DR
Diabetes Care; 2018 Nov; 41(11):2297-2305. PubMed ID: 30131399
[TBL] [Abstract][Full Text] [Related]
34. Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes.
Virk SA; Donaghue KC; Cho YH; Benitez-Aguirre P; Hing S; Pryke A; Chan A; Craig ME
J Clin Endocrinol Metab; 2016 Sep; 101(9):3257-63. PubMed ID: 27186858
[TBL] [Abstract][Full Text] [Related]
35. Neutrophil-to-lymphocyte ratio and microvascular complications in subjects with type 2 diabetes: Pakistan’s perspective.
Fawwad A; Butt AM; Siddiqui IA; Khalid M; Sabir R; Basit A
Turk J Med Sci; 2018 Feb; 48(1):157-161. PubMed ID: 29479977
[TBL] [Abstract][Full Text] [Related]
36. Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study.
Borgharkar SS; Das SS
BMJ Open Diabetes Res Care; 2019; 7(1):e000654. PubMed ID: 31413840
[TBL] [Abstract][Full Text] [Related]
37. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140
[TBL] [Abstract][Full Text] [Related]
38. Diagnosing type 2 diabetes using Hemoglobin A1c: a systematic review and meta-analysis of the diagnostic cutpoint based on microvascular complications.
Butler AE; English E; Kilpatrick ES; Östlundh L; Chemaitelly HS; Abu-Raddad LJ; Alberti KGMM; Atkin SL; John WG
Acta Diabetol; 2021 Mar; 58(3):279-300. PubMed ID: 33141338
[TBL] [Abstract][Full Text] [Related]
39. Is there a need to optimize glycemic control in hemodialyzed diabetic patients?
Feldt-Rasmussen B
Kidney Int; 2006 Oct; 70(8):1392-4. PubMed ID: 17024163
[TBL] [Abstract][Full Text] [Related]
40. [Type 2 diabetes complications].
Schlienger JL
Presse Med; 2013 May; 42(5):839-48. PubMed ID: 23528336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
